Joshua DeTillio - Mar 1, 2025 Form 4 Insider Report for Nutex Health, Inc. (NUTX)

Role: Chief Operating Officer
Signature: /s/ Joshua DeTillio
Stock symbol: NUTX
Transactions as of: Mar 1, 2025
Transactions value $: -$32,588
Form type: 4
Date filed: 4/14/2025, 04:01 PM
Previous filing: Aug 21, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NUTX	Common Stock	Options Exercise	$0	+2.13K	+44.2%	$0.00	6.93K	Mar 1, 2025	Direct	F1
transaction	NUTX	Common Stock	Tax liability	-$32.6K	-452	-6.52%	$72.10	6.48K	Apr 4, 2025	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NUTX	Restricted Stock Units	Options Exercise	$0	+5.95K	+140%	$0.00	10.2K	Mar 1, 2025	Common Stock	5.95K	$0.00	Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Restricted stock units convert into common stock on a one-for-one basis.
F2	Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations.
F3	On March 10, 2025, the Reporting Person was granted 5,950 RSUs, which vest in three equal installments on March 1, 2026, March 1, 2027, and March 1, 2028.